Ascendis Pharma A/S (ASND)
252.33
+0.38
(+0.15%)
USD |
NASDAQ |
Aug 25, 15:16
Ascendis Pharma Price : 252.33 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 256.35 | 256.35 | 247.03 | 251.95 | 329924.0 |
| Aug 21, 2026 | 253.62 | 257.88 | 252.87 | 253.29 | 363774.0 |
| Aug 20, 2026 | 256.65 | 260.98 | 253.21 | 254.81 | 533645.0 |
| Aug 19, 2026 | 255.00 | 261.61 | 251.11 | 259.62 | 541222.0 |
| Aug 18, 2026 | 246.47 | 253.55 | 245.68 | 248.85 | 452633.0 |
| Aug 17, 2026 | 246.33 | 250.62 | 242.00 | 247.40 | 607654.0 |
| Aug 14, 2026 | 243.63 | 249.52 | 240.64 | 248.50 | 650359.0 |
| Aug 13, 2026 | 250.38 | 251.43 | 244.12 | 246.23 | 1.061M |
| Aug 12, 2026 | 253.92 | 258.54 | 251.92 | 255.46 | 440053.0 |
| Aug 11, 2026 | 256.70 | 258.48 | 252.26 | 254.57 | 418491.0 |
| Aug 10, 2026 | 255.01 | 257.42 | 251.00 | 255.62 | 423479.0 |
| Aug 07, 2026 | 251.76 | 257.57 | 251.76 | 255.41 | 325562.0 |
| Aug 06, 2026 | 244.70 | 254.98 | 244.70 | 249.85 | 746643.0 |
| Aug 05, 2026 | 246.64 | 249.50 | 243.57 | 244.20 | 486261.0 |
| Aug 04, 2026 | 245.90 | 247.98 | 239.56 | 244.59 | 791828.0 |
| Aug 03, 2026 | 244.68 | 245.66 | 239.93 | 243.45 | 622951.0 |
| Jul 31, 2026 | 249.71 | 252.46 | 243.30 | 243.91 | 508878.0 |
| Jul 30, 2026 | 250.00 | 253.06 | 245.84 | 251.07 | 475233.0 |
| Jul 29, 2026 | 254.94 | 260.22 | 251.66 | 252.05 | 507091.0 |
| Jul 28, 2026 | 255.53 | 255.53 | 246.62 | 254.44 | 578554.0 |
| Jul 27, 2026 | 255.56 | 258.58 | 252.93 | 253.42 | 365408.0 |
| Jul 24, 2026 | 254.40 | 258.86 | 251.99 | 253.86 | 390366.0 |
| Jul 23, 2026 | 251.55 | 256.09 | 249.99 | 252.66 | 308315.0 |
| Jul 22, 2026 | 255.20 | 257.71 | 251.68 | 251.93 | 412324.0 |
| Jul 21, 2026 | 252.72 | 257.12 | 250.03 | 255.20 | 549020.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Evaxion AS | 3.44 |
| Genmab A/S | 34.22 |
| Zealand Pharma A/S | 48.24 |
| Cellectis SA | 3.37 |
| BioMarin Pharmaceutical, Inc. | 65.95 |
Price Related Metrics
| PE Ratio | 19.23 |
| PS Ratio | 13.18 |
| Price to Book Value | 10.09 |
| Price to Free Cash Flow | 41.37 |
| Earnings Yield | 5.20% |
| Market Cap | 16.57B |
| Operating PE Ratio | 127.71 |
| Normalized PE Ratio | 19.23 |